Low Prevalence of TP53 Mutations and MDM2 Amplifications in Pediatric Rhabdomyosarcoma
The tumor suppressor gene TP53 is the most commonly mutated gene in human cancer. The reported prevalence of mutations in rhabdomyosarcoma (RMS) varies widely, with recent larger studies suggesting that TP53 mutations in pediatric RMS may be extremely rare. Overexpression of MDM2 also attenuates p53...
Main Authors: | Simona Ognjanovic, Ghyslaine Martel, Carlos Manivel, Magali Olivier, Erica Langer, Pierre Hainaut |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Sarcoma |
Online Access: | http://dx.doi.org/10.1155/2012/492086 |
Similar Items
-
The IARC TP53 mutation database: a resource for studying the significance of TP53 mutations in human cancers
by: Magali Olivier, et al.
Published: (2007-02-01) -
TP53 and Beta-catenin mutations in liver tumours
by: Pierre Hainaut
Published: (2007-02-01) -
MDM2 Amplification and PI3KCA Mutation in a Case of Sclerosing Rhabdomyosarcoma
by: Ken Kikuchi, et al.
Published: (2013-01-01) -
Effects of MDM2, MDM4 and TP53 codon 72 polymorphisms on cancer risk in a cohort study of carriers of TP53 germline mutations.
by: Shenying Fang, et al.
Published: (2010-05-01) -
TP53 and MDM2 alterations in human bladder cancer
by: Abdel-Fattah, Rana
Published: (1997)